-
1
Eligibility for sacubitril–valsartan in patients with acute decompensated heart failure
Published 2020-06-01Subjects: Get full text
Article -
2
Left ventricular output indices and sacubitril/valsartan titration: role of stroke volume index
Published 2022-06-01Subjects: “…Sacubitril…”
Get full text
Article -
3
-
4
Use of sacubitril/valsartan in non‐compaction cardiomyopathy: a case report
Published 2020-06-01Subjects: Get full text
Article -
5
Effect of sacubitril/valsartan on inflammation and oxidative stress in doxorubicin-induced heart failure model in rabbits
Published 2021-09-01Subjects: “…sacubitril…”
Get full text
Article -
6
Fulminant myocarditis caused by immune checkpoint inhibitor: a case report and possible treatment inspiration
Published 2022-06-01Subjects: Get full text
Article -
7
Early experience of Sacubitril–Valsartan in heart failure with reduced ejection fraction in real‐world clinical setting
Published 2020-06-01Subjects: Get full text
Article -
8
Progress in Managing Heart Failure: an in-depth Review of Sacubitril/Valsartan Combination Therapy
Published 2024-04-01Subjects: Get full text
Article -
9
Sacubitril/valsartan in patients with heart failure with reduced ejection fraction with end‐stage of renal disease
Published 2020-06-01Subjects: “…Sacubitril/valsartan…”
Get full text
Article -
10
The role of sacubitril/valsartan in abnormal renal function patients combined with heart failure: a meta-analysis and systematic analysis
Published 2024-12-01Subjects: “…Sacubitril/valsartan…”
Get full text
Article -
11
-
12